Suli Dai
12 Health Road
Shijiazhuang, 050000, China
Shijiazhuang, 050000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Retraction Note: LncRNA CCAT1 facilitates the progression of gastric cancer via PTBP1-mediated glycolysis enhancement.
Journal: Journal of experimental & clinical cancer research : CR
Published: May 15, 2026
CircSPARC promotes esophageal squamous cell carcinoma through an HNRNPC-EPN2 splicing axis that activates Wnt/β-Catenin signaling.
Journal: Molecular cancer
Published: November 28, 2025
Robust CD8+ T cell responses induced by an mRNA-LNP vaccine encoding rat HER2 extracellular domain confer prophylactic tumor protection.
Journal: Frontiers in immunology
Published: November 02, 2025
A Novel Autophagy Inhibitor p-Hydroxylcinnamaldehyde Suppresses Esophageal Squamous Cell Carcinoma by Targeting LDHA Phosphorylation-Mediated Metabolic Reprogramming.
Journal: Research (Washington, D.C.)
Published: September 12, 2025
Hypoxia Induced Lnc191 Upregulation Dictates the Progression of Esophageal Squamous Cell Carcinoma by Activating GRP78/ERK Pathway.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 16, 2024
Unveiling the therapeutic potential: KBU2046 halts triple-negative breast cancer cell migration by constricting TGF-β1 activation in vitro.
Journal: Oncology research
Published: January 04, 2024
The NR_109/FUBP1/c-Myc axis regulates TAM polarization and remodels the tumor microenvironment to promote cancer development.
Journal: Journal for immunotherapy of cancer
Published: April 28, 2023
LncRNA CCAT1 facilitates the progression of gastric cancer via PTBP1-mediated glycolysis enhancement.
Journal: Journal of experimental & clinical cancer research : CR
Published: March 29, 2023
Last Updated: 09/26/2026